Stock Scorer

Viemed Healthcare Inc (VMD) · Peers

Viemed Healthcare against the 13 other companies here in its SEC industry, Services-Misc Health & Allied Services, Nec. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 14, highest first.

Measure by measure

MeasureVMDPeer medianRank
Market value $361.08M median $282.10M 7 of 13
P/E 24.9× median 26.2× 4 of 6
Forward P/E 22.9× median 12.6× 2 of 8
EV/EBITDA 6.7× median 15.5× 6 of 6
P/S 1.2× median 2.1× 9 of 13
FCF yield 8.1% median 2.2% 4 of 12
Gross margin 57.5% median 54.4% 4 of 10
Operating margin 7.5% median -0.5% 4 of 10
Net margin 4.8% median 3.4% 6 of 11
ROIC 12.8% median 6.4% 3 of 6
ROE 10.1% median 3.2% 4 of 10
Revenue growth (4y, yearly) 23.3% median 5.7% 4 of 10
EPS growth (yearly) 13.9% median 1.2% 1 of 6
Current ratio 1.4× median 1.9× 9 of 13
Stock pay / revenue 3.0% median 1.0% 7 of 14
Share count change 0.0% median 0.5% 6 of 10

Green where Viemed Healthcare is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
VMDViemed Healthcare Inc $361.08M P/E 24.9× 12.8% 6.1
DVADaVita HealthCare Partners Inc $11.95B P/E 14.1× 18.0% 6.0
FMSFresenius Medical Care AG $11.80B P/E – – 5.3
SHCSotera Health Co $5.11B P/E 31.2× – 4.8
PGNYProgyny, Inc. $2.06B P/E 26.2× 40.9% 6.9
AGLagilon health, inc. $1.43B P/E – – 4.4
MCTACharming Medical Ltd $474.08M P/E – – 3.1
PARKPark Dental Partners, Inc. $90.11M P/E 94.0× – 5.2
MRAIMarpai, Inc. $83.98M P/E – – 2.4
BRTXBioRestorative Therapies, Inc. $39.24M P/E – – 3.6
CCELCryo Cell International Inc $35.64M P/E – – 5.1
PFHOPacific Health Care Organization Inc $12.03M P/E 12.3× 6.4% 5.5
MGRXMangoceuticals, Inc. $6.25M P/E – -77.3% 3.3
NIVFNewGenIvf Group Ltd – P/E – -32.4% 5.5

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.